Related by context. All words. (Click for frequent words.) 66 Nasdaq IMGN 66 monocytogenes Listeria vaccines 65 stable nucleic acid 65 RNA interference RNAi therapeutics 65 Nasdaq ENZN 65 OTCBB TDLP 65 OTCBB HXBM developer 64 Inc. Nasdaq AVRX 64 Inc. Nasdaq ONTY 64 Inc. Nasdaq IMGN 64 ImmunoGen Inc. 64 AMEX ONI 63 ImmunoCellular Therapeutics Ltd. 63 TSX ONY 63 Nasdaq IMGN biopharmaceutical 63 Nasdaq TARG 63 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 63 NYSE Amex PBTH 63 OTCBB NRGX 63 Nasdaq IDIX 62 PRNewswire FirstCall Nastech Pharmaceutical 62 REGENERX BIOPHARMACEUTICALS INC. 62 NovaBay Pharmaceuticals 62 OTCBB IMUC 62 DiLA2 62 Aradigm Corporation 61 NYSE Amex RGN 61 Nasdaq MITI biopharmaceutical 61 NASDAQ PPHM clinical 61 Nastech Pharmaceutical Company 61 lipid nanoparticle 61 OTCBB OHRP 61 OTCBB INSV 61 Nasdaq HALO biopharmaceutical 61 Nasdaq HALO 61 Novelos Therapeutics Inc. 61 Nasdaq VRTX 60 Mersana Therapeutics 60 Listeria vaccine 60 NASDAQ IMCL 60 FoldRx Pharmaceuticals Inc. 60 NASDAQ LGND 60 OTCBB VCRT 60 Regado Biosciences 60 OTCBB PYTO 60 Inc. Nasdaq CYCC 60 NASDAQ INGN 60 targeted anticancer therapeutics 60 Inc. NASDAQ AEZS 60 OTCBB NVLT biopharmaceutical 60 OTCBB CGXP 60 OTCBB FCSC 60 Nasdaq PARD 60 Transdel Pharmaceuticals Inc. 60 OTCBB IMNR 60 NYSE Amex PTN 60 Inc. Nasdaq RNVS 60 Nasdaq ALNY 60 Nasdaq CRXL 60 Nasdaq IDRA 60 NasdaqCM PSTI DAX PJT 60 Nasdaq CYTR biopharmaceutical 60 NASDAQ AVEO biopharmaceutical 60 AEMD 59 Inovio Biomedical Corporation 59 humanized anti 59 Dynavax Technologies Corporation 59 NASDAQ EMIS 59 Inc. AMEX YMI 59 PROLOR Biotech Inc. 59 immunotherapeutics 59 PRNewswire FirstCall Anesiva 59 AVEO Pharmaceuticals Inc. 59 Therapeutic Competitors Companies 59 GammaCan 59 NASDAQ AVII developer 59 Ltd. OTCBB IMUC 59 AMEX INO 59 AVXL 59 Aeolus Pharmaceuticals 59 OTCBB NPHC biotechnology 59 IR BioSciences Holdings 59 VitiGam 59 NASDAQ ABII 59 Frankfurt XMP 59 liposomal delivery 58 Homspera TM 58 4SC AG ISIN DE# 58 ImmuneRegen BioSciences Inc. 58 HCV protease inhibitor 58 Ceragenix Pharmaceuticals Inc. 58 oral JAK#/JAK# inhibitor 58 NYSE Amex RNN 58 HepaLife Technologies Inc. 58 Adrenomyeloneuropathy AMN HIV 58 TSX VENTURE GAP 58 TSX CTI 58 Æterna Zentaris Inc. 58 pan HDAC inhibitor 58 novel RNAi therapeutics 58 OTCQB CTIX 58 Protalex Inc. 58 Nasdaq IDRA today 58 Inc. Nasdaq INFI 58 OTCBB DORB 58 Viprovex TM 58 commercializing oxidized glutathione 58 PRNewswire FirstCall Neurogen 58 Alfacell proprietary ribonuclease 58 Metabasis Therapeutics Inc. 58 PRNewswire FirstCall Aeterna Zentaris 58 immatics 58 nucleic acid lipid 58 JAK1 58 Repligen Corporation 58 OTCBB CHKT 58 Avila Therapeutics 58 OMRIX Biopharmaceuticals Inc. 58 AB OMXS BINV 58 novel peptide 58 antisense therapeutics 58 platinum chemotherapeutic 58 Nasdaq FOLD 58 Nasdaq TGEN 58 Neogenix 58 Quark Biotech Inc. 58 OTC BB PVCT 58 Ophthotech 58 NovaBay Pharmaceuticals Inc. 57 Amex KAL 57 catalytic antioxidant compounds 57 PRNewswire FirstCall Senomyx 57 PRNewswire FirstCall YM BioSciences 57 huC# DM4 57 Opexa Therapeutics Inc. 57 derivatives Radilex TM 57 TRACON Pharmaceuticals 57 liposomal formulation 57 Nasdaq DYAX 57 Locked Nucleic Acid 57 TSX TKM 57 NASDAQ TGEN 57 molecular imaging radiopharmaceutical 57 investigational pan BCR 57 NASDAQ SNTA biopharmaceutical 57 Nasdaq OMER 57 Applied NeuroSolutions 57 target Galectin receptors 57 AMEX REX 57 targeted radiotherapeutic 57 Nasdaq MBRX announced 57 Genaera Corporation 57 OTCBB PYTO FWB ET6 57 XSSE OXGN 57 Inotek Pharmaceuticals Corporation 57 EPIX Pharmaceuticals Inc. 57 Nasdaq ASTM 57 Inc. OTCBB ECTE 57 #/#/# Cytokinetics Incorporated 57 Nasdaq MYRX 57 Response Genetics Inc. 57 NASDAQ BTRX pharmaceutical 57 OTC Bulletin Board LWLG 57 NYSE Amex JAV 57 YM AIM YMBA 57 NASDAQ SNTA 57 Inc. OTCBB OXIS 57 Tekmira Pharmaceuticals Corporation 57 RNA antagonists 57 novel immunomodulatory 57 acetonide FA 57 NASDAQ IMCL global 57 Nasdaq RXII 57 Lipid Sciences Inc. 57 NASDAQ FLML 57 commercializing anti infective 57 NASDAQ CYTR biopharmaceutical 57 AMEX ISV 57 ChemoCentryx 57 Nasdaq RGDX 57 SMARTICLES ® 56 Tarvacin TM 56 NASDAQ CORT 56 Nasdaq AFFY today 56 Survivin antagonist 56 Nasdaq AEZS 56 TSX VIR 56 inhaled formulation 56 Liprotamase 56 Nasdaq OMER biopharmaceutical 56 OTCBB CTIX 56 Tumour Vascular Disrupting Agent 56 Nasdaq XTLB 56 NYSE Amex AEN 56 AngioChem 56 NASDAQ AEZS TSX AEZ 56 antisense drug 56 Hybridon 56 Tumor Activated Prodrug TAP 56 PNP inhibitor 56 OTCBB IMUC biotechnology 56 DURECT proprietary 56 Cynapsus Therapeutics Inc. 56 NanoViricides Inc. 56 novel antibody therapeutics 56 M2 subunit 56 FOLOTYN ® 56 Alvine Pharmaceuticals 56 Urigen Pharmaceuticals Inc. 56 orally administered pharmacological chaperones 56 Logical Therapeutics 56 symbol AVXL 56 targeted anticancer biopharmaceuticals 56 MVA BN R 56 OTCBB QTXB 56 molecular chaperone regulation 56 Myrexis Inc. 56 Onalta 56 NASDAQ DYAX 56 AVANIR Pharmaceuticals Inc. 56 Locked Nucleic Acid LNA 56 Cynapsus formerly 56 PNT# 56 proprietary PEGylation 56 TSX YM AIM 56 IMiDs R 56 novel anti infective 56 Receptos 56 OTCBB HPLF FWB HL1 56 Cellgate Inc. 56 QuantRx Biomedical Corporation 56 rxRNA 56 Tranzyme Pharma 55 Pervasis 55 Omeros Corporation 55 including thyroiditis RA 55 NYSE Amex NBY clinical 55 vinca alkaloid 55 Inc. OTCBB LPTN 55 Inc. NASDAQ CRIS 55 OTCBB CVBT 55 OTCBB DORB DOR 55 CEQ# 55 PEG SN# 55 exon skipping 55 CRMD pharmaceutical 55 Amex PTN 55 novel immunotherapies 55 Pervasis Therapeutics Inc. 55 VIA Pharmaceuticals 55 peptibody 55 delivered RNAi therapeutic 55 small molecule agonists 55 Inc. Nasdaq ALNY 55 VaxInnate 55 VentiRx 55 vivo electroporation 55 Unigene Laboratories Inc. 55 TIMERx R 55 DiLA2 platform 55 Ron Bentsur 55 Aganocide ® 55 Inc. Nasdaq RNAI 55 Epiphany Biosciences 55 antiviral therapeutics 55 Nanobody 55 Nasdaq GENR 55 OTCBB NRGX biotechnology 55 Provectus Pharmaceuticals specializes 55 epothilones 55 NASDAQ ALNY 55 Xanthus Pharmaceuticals Inc. 55 MEK inhibitor 55 Personalized Immunotherapy 55 PRNewswire FirstCall Sirna Therapeutics 55 DiLA 2 55 NASDAQ EPIX 55 Oracea TM 55 Epeius Biotechnologies Corporation 55 Nasdaq ENMD 55 small molecule defensin 55 Fc fusion protein 55 BioSilicon TM 55 NYSE Alternext ULU 55 Regulus Therapeutics 55 IMiDs ® 55 therapeutic monoclonal antibody 55 nanomedicines 55 Avian Transgenic Technology 55 Company Euronext OCTO 55 Nasdaq IMGN biotechnology 55 HQK 55 Etubics 55 CNW Telbec Aeterna Zentaris 55 Antigen Express 55 Acuity Pharmaceuticals 55 Immtech Pharmaceuticals Inc. 55 platform HDL Mimetic 55 Brussels THR 55 Corp. Nasdaq BSTC 55 transthyretin TTR mediated amyloidosis 54 OncoVEX 54 Nasdaq LXRX biopharmaceutical 54 therapeutic monoclonal antibodies 54 FoldRx 54 proven DuraSite ® 54 AAG geldanamycin analog 54 Enhanze TM Technology 54 NASDAQ ZIOP announced 54 isoform selective 54 initiated Phase 1b 54 Fero Industries Inc. 54 Nasdaq KOSN 54 DOR BioPharma Inc. 54 MTP inhibitor 54 PKC# 54 Omacetaxine 54 tkRNAi 54 Inc. NASDAQ CLDA 54 Merck Serono division 54 humanized monoclonal antibodies 54 Chemokine Therapeutics 54 TSX VENTURE CTH 54 Tekmira SNALP stable 54 Nasdaq IDIX biopharmaceutical 54 histone deacetylase HDAC inhibitor 54 Salmonella vector 54 Sangamo BioSciences 54 Agios Pharmaceuticals 54 investigational humanized monoclonal antibody 54 CAMBRIDGE Mass. Alnylam Pharmaceuticals 54 Profectus BioSciences 54 Galenea 54 JAK2 inhibitor 54 anticancer therapeutics 54 THR beta agonist 54 Gemin X 54 oral prodrug 54 Diatos 54 ALN TTR 54 theranostic 54 lead molecular radiotherapeutic 54 TSX AMB 54 siRNA therapeutic 54 PEGylated 54 KL4 Surfactant 54 multi kinase inhibitor 54 PROfusion 54 lipid particles SNALP 54 Inc. Nasdaq IDMI 54 anticoagulant reversing agent 54 bio therapeutics 54 SNALP technology 54 commercialize Aganocides 54 Myolimus 54 NASDAQ OPXA 54 Archemix Corp. 54 TSX VENTURE DMA 54 AAV vector 54 Adenosine Therapeutics 54 ALN PCS 54 developing chemokine 54 oncolytic viruses 54 www.ucb group.com 54 oral transdermal 54 targeting CD# 54 NASDAQ CYTR 54 MDRNA proprietary 54 tiapamil 54 Intarcia 54 siRNA compounds 54 Inc. NASDAQ IDMI 54 Helix BioMedix Inc. 53 myelofibrosis polycythemia vera 53 Inc. OTCBB IRBS 53 novel antiviral therapeutics 53 ophthalmic therapeutics 53 mediate RNAi 53 acne impetigo 53 rusalatide acetate 53 EyeGate Pharma 53 mda 7 53 Inc. NASDAQ AGIX 53 DsiRNA 53 HCV protease 53 Affimed 53 NASDAQ ALTH biopharmaceutical 53 Xytis 53 ALN VSP 53 Nile Therapeutics 53 small molecule 53 product platforms AZX# 53 OTCBB CHKT biotechnology 53 NexACT R 53 Familial Adenomatous Polyposis FAP 53 Ambrx 53 Celsion Corporation 53 Nuron Biotech 53 Vaccinex 53 Affimed Therapeutics AG 53 motexafin gadolinium Injection 53 Fleximer R 53 passive immunotherapy products 53 expanded autologous cellular 53 personalized cellular immunotherapy 53 generation antisense 53 Callisto Pharmaceuticals Inc. 53 CYT# potent vascular disrupting 53 DPX Survivac 53 IAP inhibitor 53 BHT DNA 53 Ibis T# TM 53 immunologic diseases 53 Ph.D. Targacept 53 RNAi therapeutics 53 liposomal 53 sulfonylhydrazine class 53 Nasdaq MNKD focused 53 enhance ApoA 53 systemic RNA interference 53 Corporation Nasdaq CRGN 53 lipid particles 53 Selective Electrochemical Tumor Ablation 53 novel immunotherapeutic 53 Initiates Phase II 53 c Raf kinase 53 ArQule Kinase Inhibitor Platform 53 Akebia Therapeutics 53 Aegis Therapeutics 53 Merrimack Pharmaceuticals 53 Affibody ® molecules 53 Solazed TM 53 Friedreich Ataxia FRDA 53 selective kinase inhibitor 53 OTCBB PVCT 53 TSX BSY 53 RONDEL ™ 53 J. Mazzo Ph.D. 53 Celator 53 OGeS 53 Ceregene 53 UltiMAb 53 BCR ABL inhibitors 53 EOS NASDAQ MELA 53 novel VDA molecule 53 IAP inhibitors 53 RNAi therapeutic targeting 53 targeting PCSK9 53 candidates Azedra TM 53 allosteric modulation 53 AKIP ™ 53 MPH AMEX 53 modified glutathione analog 53 peptide peptide mimetic 53 orally bioavailable 53 Protein Polymer Technologies 53 BXT # 53 histone deacetylase HDAC 53 ArQule Kinase Inhibitor 53 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 53 potently inhibit 53 RNA antagonist 53 Calistoga Pharmaceuticals 53 CCR9 antagonist 53 PRTX 53 AKIP TM 53 Cerulean Pharma Inc. 53 Prodarsan R 53 RECOTHROM ® 52 Oxis International 52 oral ghrelin agonist 52 Anticalins R 52 Unit Dose Budesonide 52 Novosom 52 infectious diseases autoimmune diseases 52 novel peptides 52 kidney urologic 52 engineered RAP peptides 52 Sangamo BioSciences Inc. 52 Panzem R 52 pralatrexate injection folate analogue 52 cancer immunotherapies 52 Scancell 52 Cempra Pharmaceuticals 52 XmAb ® 52 short interfering RNA 52 Rib X 52 FGFR 52 ANG# 52 Affibody 52 Fleximer 52 ERYtech Pharma 52 coronary stent merged 52 synthetic retinoid 52 humanized antibodies 52 Anticalin R 52 targeted immunotherapies 52 Neurogen Corporation 52 AtuRNAi 52 intranasal delivery 52 BioWa 52 siRNA delivery 52 GlycoMimetics 52 anti infective treatments 52 Viprovex R 52 San Diego Amira Pharmaceuticals 52 IMA# 52 Tarmogen 52 PDE4 inhibitor 52 lentiviral vector 52 HSP# inhibitor 52 angiogenesis inhibitor 52 immuno pharmaceutical 52 GAP #B# 52 3 kinase PI3K 52 Spectrum Pharmaceuticals acquires 52 ribonucleotide reductase clinically validated 52 Locus Pharmaceuticals 52 BiTE antibody 52 Inc. Nasdaq IMMU 52 GlycoPEGylated hemostasis compounds 52 antibacterial therapeutics 52 miRNA therapeutics 52 JAK inhibitor 52 Therapies SRT 52 Hsp# inhibitor 52 recombinant vaccines 52 P#X# antagonist 52 proteasome inhibitor 52 antisense drugs 52 Curaxin CBLC# 52 Abiraterone acetate 52 ALN TTR# 52 Kane Biotech 52 RNAi therapeutic 52 antagomirs 52 Announces Poster Presentations 52 antibody fragment therapeutics 52 Synergy Pharmaceuticals 52 Aerosurf 52 Akela Pharma Inc. 52 Cetrorelix 52 Guanilib 52 NP2 Enkephalin 52 proprietary Dicer Substrate Technology 52 NASDAQ CYPB 52 selective inhibition 52 imaging radiopharmaceuticals 52 barrier gauze dressings 52 Ii protein 52 Angiocept 52 KineMed 52 Intradigm Corporation 52 Neuro Hitech 52 Dicer Substrate Technology 52 ImmunoCellular Therapeutics 52 A3 adenosine receptor 51 TSX AEZ 51 Nasdaq IMMU biopharmaceutical 51 AMEX KAL 51 RhuDex ® 51 NEUGENE R 51 lipid nanoparticles 51 Alnylam Pharmaceuticals 51 LentiVector technology 51 oncology therapeutics 51 small molecule therapeutics 51 Curaxin 51 radezolid 51 investigational monoclonal antibody 51 PharmFilm ® 51 Eligen ® Technology 51 human antibody therapeutics 51 ELADUR ™ 51 VisEn Medical 51 PEGylation technology 51 Inc. OTCBB SNWV 51 migraines neurorehabilitation 51 Aviptadil 51 Nektar PEGylation technology 51 antisense oligonucleotide 51 G Protein Coupled 51 Sphingomab 51 customizable drug eluting 51 metaglidasen 51 RenaZorb TM 51 immunotherapeutic 51 Romidepsin 51 commercializing therapeutic 51 SMaRT ™ 51 Zysolin TM 51 CYT# novel 51 Sudhir Agrawal D.Phil 51 Nanobody ® 51 Ception Therapeutics 51 RONDEL TM 51 Ostabolin C TM 51 CD# CEA 51 entinostat 51 HCV polymerase inhibitors 51 ApoB SNALP 51 oral Janus kinase 51 commercialize deforolimus 51 protease inhibitor telaprevir 51 BYETTA ® 51 Rhucin ® recombinant 51 Inc. Nasdaq NLTX 51 Cyclosert TM 51 Promedior 51 Phenomix Corporation 51 Tod Woolf Ph.D. 51 Clavis Pharma 51 ANAVEX 51 Spiro Rombotis President 51 polyneuropathy HIV DSP 51 AtuPLEX 51 human monoclonal antibody 51 novel therapeutic antibodies 51 mucosal vaccines 51 Elixir Pharmaceuticals 51 DepoVax 51 PI3K/Akt pathway inhibitor 51 Stapled Peptide 51 molecular chaperone 51 immune modulatory 51 StromaCel Inc. 51 Ore Pharmaceuticals 51 PEGylation 51 TLR9 agonists 51 Resolvyx Pharmaceuticals 51 Trophos 51 Edward Lanphier Sangamo 51 Dr. Aiping Young 51 OTCQB ABPI 51 SR Pharma 51 TSX AHX 51 humanized antibody 51 investigational compounds 51 Azedra 51 Hana Biosciences 51 PsychoGenics 51 molecular imaging radiopharmaceuticals 51 ZFN TM 51 nitric oxide donating 51 Board LWLG technology 51 gastro intestinal inflammation 51 OTCBB AEMD pioneer 51 LNPs 51 immunomodulators 51 osteolytic bone disease 51 Pulmo BioTech Inc. 51 Inc. Nasdaq VIAP 51 dermatology therapies 51 Soliris eculizumab 50 vinca alkaloids 50 monoclonal antibodies 50 cyclophilin inhibitors 50 Tranzyme 50 OXIGON TM 50 KL4 surfactant 50 Dyax phage display 50 botanical therapeutics 50 Epizyme 50 oral salmon calcitonin 50 Alnylam Pharmaceuticals Inc. 50 doxorubicin Transdrug R 50 immune modulating drug 50 diabetes irritable bowel 50 Amedica Corporation 50 monoclonal antibody 50 Tarvacin 50 acting muscarinic antagonist 50 Combivir Kivexa 50 Morria Biopharmaceuticals Plc 50 Genesis Biopharma Inc. 50 Aerie Pharmaceuticals 50 Intravenous CP 50 LNP formulations 50 Adnectin 50 TÎ ² 4 50 NexACT 50 selective androgen receptor modulators 50 Mesoblast Limited ASX MSB 50 PROT biotechnology 50 HSP# inhibitors 50 Hemopurifier TM 50 prostone 50 resolvin 50 biotherapeutics 50 BiTE 50 NovaBay Aganocide compounds 50 oncolytic 50 vaccine GRNVAC1 50 TKB# 50 drugable targets 50 IXSBF 50 Xanafide 50 ADVEXIN p# therapy 50 Protein Kinase C 50 PHX# 50 tranilast 50 Litx 50 familial amyloidotic polyneuropathy FAP 50 TPI ASM8 50 Javelin Pharmaceuticals AMEX JAV 50 DNA methylation biomarkers 50 humanized monoclonal antibody 50 Symphogen 50 MP4 molecule 50 Angiochem 50 metalloenzymes 50 Supernus Pharmaceuticals 50 buccal delivery 50 rxRNA compounds 50 Adeona Pharmaceuticals Inc. 50 SNALP 50 Charlesson 50 Epothilones 50 antibiotic anti infective 50 NASDAQ EPIX biopharmaceutical 50 Uli Hacksell Ph.D. 50 Bioral 50 Sphingomab TM 50 Transdel TM 50 Karo Bio 50 antibody therapeutics 50 AN# novel 50 relapsed leukemia 50 anticancer compounds 50 nicotinic alpha 7 50 Anacor 50 antisense 50 OMP #M# 50 Rebif ® 50 biased ligand 50 Tekmira SNALP technology 50 OncoVEX GM CSF 50 ALN HTT 50 OTCBB FCSC biotechnology 50 NeuroMedix 50 polymerase inhibitors 50 novel therapeutics 50 SCYNEXIS 50 fusion proteins 49 renin inhibition promising 49 SPC# [001] 49 Phylogica 49 Stemgent 49 superior bioprocessing 49 TorreyPines Therapeutics Inc. 49 Oramed 49 LentiVector 49 siRNAs targeting 49 Anaphore 49 Kamada AAT 49 aTyr Pharma 49 ARIAD 49 CR# vcMMAE 49 Receptors GPCRs 49 renin inhibitor 49 CTLA4 Ig 49 sodium glucose cotransporter 49 non nucleoside HCV 49 romazarit 49 COX Inhibiting Nitric Oxide 49 Hepatitis C Virus HCV 49 TTR gene 49 Amarantus 49 Syndax Pharmaceuticals Inc. 49 URG# 49 systemic RNAi 49 Curaxins 49 EyeGate 49 molecular radiotherapeutics 49 siRNA therapeutics 49 CINTREDEKIN BESUDOTOX 49 therapeutic peptides 49 biologic therapeutics 49 Alnylam #x# 49 Semafore 49 transdermal delivery 49 2 inhibitor CYT# 49 NTDDS 49 Adherex Technologies Inc. 49 MyVax ® 49 Zalicus 49 oncolytic vaccine 49 ALV# 49 herpes simplex viruses 49 siRNA conjugates 49 Mersana 49 TSX VENTURE KNE biotechnology 49 HIF biology 49 immunological diseases 49 Inc. Nasdaq ACHN 49 Amir Avniel 49 CobaCyte 49 NuMimetic TM 49 DOS# 49 chemically modified siRNA 49 autologous cell 49 commercializing aptamer therapeutics 49 vascular disrupting agent 49 vascular disrupting agents 49 antiangiogenesis therapies 49 selective angiogenic kinase inhibitor 49 MyVax R 49 Psynova 49 Inc. Nasdaq ANTH 49 Factor VIIa 49 TARIS 49 JAK inhibitors 49 AKIP 49 Anticalins ® 49 Ampligen ® 49 engineered proteases 49 small molecule PEGylation 49 Aegera 49 Aganocide R 49 AKELA Pharma Inc. 49 sodium thiosulfate STS 49 non alcoholic steatohepatitis 49 Captisol 49 Aganocide compounds 49 Company Nasdaq RGDX 49 ATL# [001] 49 prostones 49 J. Donald deBethizy 49 OHR/AVR# 49 NNR Therapeutics TM 49 Pressure BioSciences Inc. 49 myeloproliferative disorders 49 photodisinfection 49 AAV vectors 49 factor receptor FGFR 49 Aganocide 49 neovascular diseases 49 AKT inhibitor 49 IgG1 antibody 49 OvaRex R 49 Viamet 49 bioinnovation 49 NexACT ® technology 49 NeoLipid R 49 protein therapeutics 49 Preclinical studies suggest 49 ActivX 49 TOPIGEN 49 XmAb 49 ASONEP TM 49 melanocortin receptor agonists 49 Affinium Pharmaceuticals 49 GGF2 49 targeted radiotherapeutics 49 commercialize microRNA therapeutics 49 Plexxikon 48 antisense inhibitors 48 RNA interference RNAi 48 Tß4 48 DiLA2 Platform 48 relapsed multiple myeloma 48 Enkephalin 48 MacuSight 48 cardio renal 48 BioSeek 48 vaccines oncolytic virus 48 Adrian Hobden Ph.D. 48 monoclonal antibody therapeutics 48 Bavarian Nordic patented 48 Fodosine 48 immunotherapies 48 DCVax R 48 small molecule activators 48 Nasdaq PARD biopharmaceutical 48 Microplasmin 48 Chrysalin 48 MAXY G# 48 p# inhibitor 48 Ikonisys 48 ophthalmology oncology 48 proprietary biomaterials 48 cancer therapeutics 48 systemic lupus erythematosus psoriasis 48 Squalamine 48 Genaissance Pharmaceuticals Inc. 48 BioMarin develops 48 thetreatment 48 Sym# 48 ProSavin 48 therapeutic peptide 48 ZFP TF 48 Hsp# inhibitors 48 neuroprotective properties 48 Archexin 48 vitreoretinal disorders 48 phase IIa clinical 48 blood serum biomarkers 48 Prodarsan ® 48 ATL# [002] 48 Cyclosert 48 Spiegelmers ® 48 DNAi 48 preclinical compounds 48 Alzheimer disease cognitive impairment 48 therapeutic antibody 48 KemPharm 48 Regado 48 Tissue Repair Company 48 drug ISA# 48 INS# [001] 48 nanoviricides 48 therapeutic antibodies 48 autologous cellular therapies 48 SGLT Inhibitors 48 Nautilus Biotech 48 iPSC technology 48 RNAi Therapeutics 48 PLK1 SNALP 48 Smac mimetics 48 anticancer agents 48 Bioral R 48 AEG# 48 UsiRNAs 48 Pentad TM 48 NasdaqGM SPPI commercial 48 signal transduction inhibitors 48 pharmacogenomic tests 48 Akesis Pharmaceuticals 48 TG# [003] 48 sd rxRNA compounds 48 adrenal steroid hormones 48 Cerashield 48 Metaphore 48 oral antiviral 48 antisense oligonucleotides 48 INCB# [001] 48 FluoroPharma 48 Can Fite 48 Chemophase 48 diabetic neuropathic pain 48 cellular immunotherapy 48 talactoferrin 48 Aileron Therapeutics 48 vosaroxin 48 Inc. AMEX AEN 48 liposomal formulations 48 MediVas 48 ophthalmology dermatology cardiovascular disease 48 hematological cancers 48 microRNA therapeutics 48 pharmacological chaperone 48 XmAb# 48 adrenergic regulation 48 commercializes biotherapeutics 48 Neuroptix 48 biochemical profiling 48 Metallophile ™ Technology 48 NEUGENE 48 novel orally administered 47 siRNA sequences 47 histone deacetylase 47 Biomoda www.biomoda.com 47 New Chemical Entities 47 Cobalamin TM mediated 47 hypoxia activated prodrug 47 histone deacetylase HDAC inhibitors 47 Allovectin 7 R 47 sirtuin inhibitor program 47 immuno inflammatory diseases 47 Tolerx 47 GRN# 47 Zingo TM 47 Ceflatonin R 47 small molecule modulators 47 anti infective compounds 47 Panzem 47 Lorus biopharmaceutical company 47 Xenon Pharmaceuticals 47 PORxin TM 47 Kleanthis G. Xanthopoulos Ph.D. 47 optimal dosing regimens 47 Diasome 47 ReVision Optics 47 iSONEP TM 47 commercializes therapeutics 47 PI3 kinase inhibitors 47 gallium containing 47 biotherapeutic 47 Ceflatonin 47 Cobalamin 47 PluriCells TM 47 topical anti infective 47 proprietary Biochronomer 47 TLR antagonists 47 Injury ALI 47 using ImmunoGen TAP 47 Orexo 47 theranostics 47 POSIDUR TM ELADUR TM